Laboratory confirmed shigellosis in Malagasy children
DOI:
https://doi.org/10.18203/2320-6012.ijrms20221329Keywords:
Antibiotic, Laboratory, Paediatry, Serotype, ShigellaAbstract
Background: Diarrheal diseases are a major public health problem in developing countries with high mortality and morbidity rates, especially among children. Shigella species is the leading cause of paediatric bacterial diarrhea and shigellosis data are very scarce in Madagascar.
Methods: A 3 year retrospective study from January 2018 to December 2020, at the University Hospital Mother and Child Tsaralalàna laboratory was performed to assess the bacteriological and epidemiological characteristics of laboratory confirmed shigellosis cases.
Results: During the study period, 298 stool samples were examined, of which 48 (16.1%) were positive for Shigella sp. The mean age of infected children was 29.7 months, predominantly in the 24-59 months age group. The infection was found mainly in male children (56.2%). Most isolates of Shigella sp showed resistance to co-trimoxazole and amoxicillin. All the strains were susceptible to third-generation cephalosporins. Of the isolated Shigella sp, 14 strains were tested for species identification and serotyping, twelve of which were Shigella flexneri and two were Shigella sonnei. The most frequent serotypes were S. flexneri 1b and 2a.
Conclusions: This study found a Shigella sp positivity rate of 16.1%. This pathogen frequently infects infants age group. Bacteriology laboratory surveillance and a multicenter survey are essential to control the spread of drug-resistant Shigella and to monitor circulating strains and the burden of this disease. Awareness of water, hygiene and sanitation (WASH) and community water supply is also necessary to reduce this infection.
References
Nicolas X, Granier H, LeGuen P. Shigellose ou dysenterie bacillaire. Presse Médicale. 2007;36:1606‑18.
Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet. 2013;382(9888):209‑22.
Kazi A, Ismail CMK, Anthony AA, Chuah C, Leow CH, Lim BH, et al. Designing and evaluation of an antibody-targeted chimeric recombinant vaccine encoding Shigella flexneri outer membrane antigens. J Molecul Epidemiol Evolution Genet Infect Dis. 2020;80:104176.
Miron D, Sochotnick I, Yardeni D, Kawar B, Siplovich L. Surgical complications of shigellosis in children. Pediat Infect Dis J. 2000;19(9):898-900.
Cruz CBN, Souza MCS, Serra PT, Santos I, Balieiro A, Pieri FA, et al. Virulence factors associated with pediatric shigellosis in Brazilian Amazon. BioMed Res Int. 2014.
Sangeetha AV, Parija SC, Mandal J, Krishnamurthy S. Clinical and microbiological profiles of shigellosis in children. J Health Populat Nutrit. 2014;32(4):580‑6.
Gentle A, Ashton PM, Dallman TJ, Jenkins C. Evaluation of molecular methods for serotyping Shigella flexneri. J Clin Microbiol. 2016;54(6):1456‑61.
Williams PCM, Berkley JA. Guidelines for the treatment of dysentery (shigellosis): a systematic review of the evidence. Paediatr Int Child Health. 2018;38(1):50‑65.
Seidlein L, Kim DR, Ali M, Lee H, Wang X, Thiem VD, et al. A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology. Plos Med. 2006;3(9):353.
Livio S, Strockbine NA, Panchalingam S, Tennant SM, Barry EM, Marohn ME, et al. Shigella isolates from the global enteric multicenter study inform vaccine development. Clin Infect Dis. 2014;59(7):933‑41.
Soraa N, Zerouali K. Shigella: Données épidémiologiques et Recommandations nationales. Société Marocaine d'Infectiologie Pédiatrique et de Vaccin. 2020.
Maladies infectieuses. Ministère de la Santé et des Services sociaux du Québec. Shigellose, 2016. Available at: https://publications.msss.gouv.qc.ca/ msss/fichiers/guide-garderie/chap7-shigellose.pdf. Accessed on 1 April 2022.
Camacho AI, Irache JM, Gamazo C. Recent progress towards development of a Shigella vaccine. Expert Rev Vaccin. 2013;12(1):43‑55.
Ansari S, Sherchand JB, Parajuli K, Mishra SK, Dahal RK, Shrestha S, et al. Bacterial etiology of acute diarrhea in children under five years of age. J Nepal Health Res Council. 2012;10(22):218‑23.
Dagnra DA, Salou M, Ekouevi DK, Nyasenu YT, Tigossou S, Prince-David M. Etiologies des diarrhees infectieuses chez les enfants de moins de cinq ans (5 ans) au Centre Hospitalier Universitaire Sylvanus Olympio de Lome de 2005 à 2009. Revue Bio-Africa. 2014;13:32-6.
Ateudjieu J, Bita’a L, Guenou E, Chebe A, Chukuwchindun BA, Goura AP, et al. Profil et antibiosensibilité des bactéries pathogènes associées aux diarrhées chez les patients consultant à l’Hôpital Régional Annexe de Kousseri, Extrême-Nord Cameroun. Pan Afr Med J. 2018;29:170-82.
Wondwossen A, Alemu E, Solomon T, Mesfin A, Adane E, Girma G. Prevalence and antibiotic susceptibility patterns of Shigella and Salmonella among children aged below five years with Diarrhoea attending Nigist Eleni Mohammed memorial hospital, South Ethiopia. BMC Pediatrics. 2018;18(1):241.
Aubry P, Gaüzère BA. Shigelloses: Actualités 2016. Med Tropical. 2016.
Sah SK, Basnet S, Shrestha S, Ghale K, Tamang S, Mandal DK, et al. Burden of Shigella spp and Vibrio spp, and their antibiotic sensitivity pattern in the patients with acute gastroenteritis in tertiary care hospital in Nepal. BMC Res Notes. 2019;12(1):699-704.
Dekker J, Frank K. Salmonella, Shigella, and Yersinia. Clin Lab Med. 2015;35(2):225‑46.
Liu J, Platts-Mills JA, Juma J, Kabir F, Nkeze J, Okoi C, et al. Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study. Lancet. 2016;388(10051):1291‑301.
Temu MM, Kaatano GM, Miyaye ND, Buhalata SN, Shushu ML, Kishamawe C, et al. Antimicrobial susceptibility of Shigella flexneri and S. dysenteriae isolated from stool specimens of patients with bloody diarrhoea in Mwanza, Tanzania. Tanzania Health Res Bull. 2007;9(3):186-9.
Daudens E, Dejour-Salamanca D, Isnard H, Mariani-Kurkdjian P, Filliol I, Bingen E. Épidémie de gastro-entérites aiguës à Shigella sonnei résistantes à l’amoxicilline, au cotrimoxazole et à l’azithromycine en Île-de-France Janvier – Avril 2007. Institut de Veille Sanitaire. Maladies Infect. 2009:21.
Yaya EL, Djeintote M, Djimeli CL, Kpinde CM, Nambei WS, et al. Contribution to the study of antibiotic resistance on Salmonella and Shigella strains isolated in Central African Republic. J Microbiol Experiment. 2017;4(1):00105.
Niyogi SK. Shigellosis. J Microbiol. 2005;43(2):133‑43.
Pourakbari B, Mamishi S, Mashoori N, Mahboobi N, Ashtiani MH, Afsharpaiman S, et al. Frequency and antimicrobial susceptibility of Shigella species isolated in Children Medical Center Hospital, Tehran, Iran, 2001-2006. Brazil J Infect Dis. 2010;14(2):153-7.
Ranjbar R, Bolandian M, Behzadi P. Virulotyping of Shigella spp. isolated from pediatric patients in Tehran, Iran. Acta Microbiologica et Immunologica Hungarica. 2017;64(1):71‑80.
Sousa MÂB, Mendes EN, Collares GB, Péret-Filho LA, Penna FJ, Magalhães PP. Shigella in Brazilian children with acute diarrhoea: prevalence, antimicrobial resistance and virulence genes. Memórias do Instituto Oswaldo Cruz. 2013;108(1):30‑5.
Sack DA, Hoque S, Etheridge M, Huq A. Is protection against shigellosis induced by natural infection with Plesiomonas shigelloides? Lancet. 1994;343(8910):1413‑5.
Shepherd JG, Wang L, Reeves PR. Comparison of O-antigen gene clusters of Escherichia coli (Shigella) Sonnei and Plesiomonas shigelloides O17: Sonnei gained its current plasmid-borne o-antigen genes from P. shigelloides in a recent event. Infect Immun. 2000;68(10):6056‑61.
Kotloff KL, Riddle MS, Platts-Mills JA, Pavlinac P, Zaidi AKM. Shigellosis. Lancet. 2018;391(10122):801‑12.
Jeong HJ, Jang ES, Han BI, Lee KH, Ock MS, Kong HH, et al. Acanthamoeba: could it be an environmental host of Shigella? Experiment Parasitol. 2007;115(2):181‑6.
